PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Comparative risks of potential adverse events following COVID-19 mRNA vaccination among older adults

JAMA Network Open

2023-08-02
(Press-News.org)

About The Study: In this study of 6.3 million older U.S. adults, the mRNA-1273 (Moderna) vaccine was associated with a slightly lower risk of several adverse events compared with BNT162b2 (Pfizer-BioNTech), possibly due to greater protection against COVID-19. Future research should seek to formally disentangle differences in vaccine safety and effectiveness and consider the role of frailty in assessments of COVID-19 vaccine performance.

Authors: Daniel A. Harris, Ph.D., of the Brown University School of Public Health in Providence, Rhode Island, is the corresponding author. 

 To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2023.26852)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.26852?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=080223

END



ELSE PRESS RELEASES FROM THIS DATE:

Moderna is safest, most effective mRNA vaccine against COVID-19 for older adults, study shows

2023-08-02
PROVIDENCE, R.I. [Brown University] — While mRNA vaccines against COVID-19 have been found to be safe and effective for the general population, in-depth evidence about safety and effectiveness for older adults and individuals with chronic health conditions is more limited. To address that gap, a team led by Brown University researchers conducted the largest head-to-head comparison study of the two mRNA vaccines approved by the U.S. Food and Drug Administration — the Moderna and Pfizer-BioNTech vaccines. The results, published in JAMA Network Open, ...

Fiber optic cables detect and characterize earthquakes

Fiber optic cables detect and characterize earthquakes
2023-08-02
In California, thousands of miles of fiber optic cables crisscross the state, providing people with internet. But these underground cables can also have a surprising secondary function: they can sense and measure earthquakes. In a new study at Caltech, scientists report using a section of fiber optic cable to measure intricate details of a magnitude 6 earthquake, pinpointing the time and location of four individual asperities, the "stuck" areas of the fault, that led to the rupture. For several years, Professor of Geophysics Zhongwen Zhan (PhD '14) ...

Potential neuropathic pain treatment shows promise in preclinical tests

2023-08-02
A non-opioid designer molecule for treating chronic neuropathic pain by calming hyperactive pain-sensing neurons in the peripheral nervous system has had promising results in a preclinical study conducted by researchers at Weill Cornell Medicine and the Burke Neurological Institute. In the study, published Aug. 2 in the British Journal of Anaesthesia, the first-in-class drug conceptualized by lead author Dr. Gareth Tibbs was found to function according to its design at both the molecular level and as an apparently side-effect-free pain reliever in rats. “With either a single dose or seven days of daily dosing, we saw a significant reversal of neuropathic pain signs in the ...

Learning how to control HIV from African genomes

2023-08-02
“We searched for human genetic variation that associates with spontaneous control of HIV and identified a novel region in the genome that is only variable in populations of African ancestries,” says Professor Jacques Fellay at EPFL’s School of Life Sciences. “We used a combination of computational and experimental approaches to explore the biological mechanism behind the genetic association and provide evidence that the gene CHD1L acts to limit HIV replication in a subset of white blood cells.” HIV is still a problem Despite significant advances in treatment and access to therapy, the ...

How the tropical red swamp crayfish successfully invaded the cold regions of Japan

How the tropical red swamp crayfish successfully invaded the cold regions of Japan
2023-08-02
Owing to human activities and climate change, many animal species have invaded new habitats. Such biological invasion comes with devastating impacts on the local biodiversity and ecosystems. The red swamp crayfish—known to the scientific world as Procambarus clarkii (P. clarkii)— is no exception. P. clarkii is a freshwater crayfish native to the tropical regions of southern USA and northeastern Mexico. After their introduction to different parts of the world, they have become one of the most widespread and invasive animal species. They are known for their adaptability and aggressive behavior that ensure their survival in a wide range of environments, ...

Breast cancer patients with higher BMI more likely to experience heart damage during chemotherapy

2023-08-02
Breast cancer survival rates have improved considerably in the last few decades in Colombia, but factors that increase the likelihood of patients experiencing cardiovascular side effects, like cardiotoxicity, are not well-known or well-treated. A recent study in the North-East region of Colombia found 11.94% of patients with a high BMI being treated for breast cancer at a regional center experienced heart damage, or cardiotoxicity, during chemotherapy. The study will be presented at the American College of Cardiology (ACC) Latin America 2023 Together with Asociación Costarricense ...

Study presents workaround for randomized experiments

2023-08-02
AUSTIN, Texas – A new statistical tool can help researchers get meaningful results when a randomized experiment, considered the gold standard, is not possible. Randomized experiments split participants into groups by chance, with one undergoing an intervention and the other not. But in real-world situations, they can’t always be done. Companies might not want to use the method, or such experiments might be against the law. Developed by a researcher at The University of Texas at Austin, the new tool called two-step synthetic control adapts an existing research workaround, known as the synthetic control method. The ...

Cal Poly study analyzes nearshore California marine heatwaves and cold spells amid changing climate conditions

2023-08-02
The first-ever study to look at drivers of both marine heatwaves and cold spells in the shallow nearshore along the California Current —coordinated by California Polytechnic State University, San Luis Obispo (Cal Poly) and the Virginia Institute of Marine Science, William & Mary — found that certain environmental conditions and the state of the ocean can lead to an enhanced risk for ocean temperature extremes.   The findings were recently published in Nature Scientific Reports in an article titled “Effects of basin-scale climate modes and upwelling on nearshore marine heatwaves and cold spells in the California Current.”   Extreme ...

Mimicking the body’s own defenses to destroy enveloped viruses

2023-08-02
Just as bacteria can develop antibiotic resistance, viruses can also evade drug treatments. Developing therapies against these microbes is difficult because viruses often mutate or hide themselves within cells. But by mimicking the way the immune system naturally deals with invaders, researchers reporting in ACS Infectious Diseases have developed a “peptoid” antiviral therapy that effectively inactivates three viruses in lab tests. The approach disrupts the microbes by targeting certain ...

Novel molecules fight viruses by bursting their bubble-like membranes

Novel molecules fight viruses by bursting their bubble-like membranes
2023-08-02
Antiviral therapies are notoriously difficult to develop, as viruses can quickly mutate to become resistant to drugs. But what if a new generation of antivirals ignores the fast-mutating proteins on the surface of viruses and instead disrupts their protective layers?   “We found an Achilles heel of many viruses: their bubble-like membranes. Exploiting this vulnerability and disrupting the membrane is a promising mechanism of action for developing new antivirals,” said Kent Kirshenbaum, professor of chemistry at NYU and the study’s senior author.   In a new study ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Comparative risks of potential adverse events following COVID-19 mRNA vaccination among older adults
JAMA Network Open